BACKGROUND: The PathOlogist is a new tool designed to transform large sets of gene expression data into quantitative descriptors of pathway-level behavior. The tool aims to provide a robust alternative to the search for single-gene-to-phenotype associations by accounting for the complexity of molecular interactions. RESULTS: Molecular abundance data is used to calculate two metrics--'activity' and 'consistency'--for each pathway in a set of more than 500 canonical molecular pathways (source: Pathway Interaction Database, http://pid.nci.nih.gov). The tool then allows a detailed exploration of these metrics through integrated visualization of pathway components and structure, hierarchical clustering of pathways and samples, and statistical analyses designed to detect associations between pathway behavior and clinical features. CONCLUSIONS: The PathOlogist provides a straightforward means to identify the functional processes, rather than individual molecules, that are altered in disease. The statistical power and biologic significance of this approach are made easily accessible to laboratory researchers and informatics analysts alike. Here we show as an example, how the PathOlogist can be used to establish pathway signatures that robustly differentiate breast cancer cell lines based on response to treatment.
BACKGROUND: The PathOlogist is a new tool designed to transform large sets of gene expression data into quantitative descriptors of pathway-level behavior. The tool aims to provide a robust alternative to the search for single-gene-to-phenotype associations by accounting for the complexity of molecular interactions. RESULTS: Molecular abundance data is used to calculate two metrics--'activity' and 'consistency'--for each pathway in a set of more than 500 canonical molecular pathways (source: Pathway Interaction Database, http://pid.nci.nih.gov). The tool then allows a detailed exploration of these metrics through integrated visualization of pathway components and structure, hierarchical clustering of pathways and samples, and statistical analyses designed to detect associations between pathway behavior and clinical features. CONCLUSIONS: The PathOlogist provides a straightforward means to identify the functional processes, rather than individual molecules, that are altered in disease. The statistical power and biologic significance of this approach are made easily accessible to laboratory researchers and informatics analysts alike. Here we show as an example, how the PathOlogist can be used to establish pathway signatures that robustly differentiate breast cancer cell lines based on response to treatment.
Authors: Rafael A Irizarry; Benjamin M Bolstad; Francois Collin; Leslie M Cope; Bridget Hobbs; Terence P Speed Journal: Nucleic Acids Res Date: 2003-02-15 Impact factor: 16.971
Authors: Blaz Zupan; Janez Demsar; Ivan Bratko; Peter Juvan; John A Halter; Adam Kuspa; Gad Shaulsky Journal: Bioinformatics Date: 2003-02-12 Impact factor: 6.937
Authors: Dominique B Hoelzinger; Luigi Mariani; Joachim Weis; Tanja Woyke; Theresa J Berens; Wendy S McDonough; Andrew Sloan; Stephen W Coons; Michael E Berens Journal: Neoplasia Date: 2005-01 Impact factor: 5.715
Authors: Roel G W Verhaak; Katherine A Hoadley; Elizabeth Purdom; Victoria Wang; Yuan Qi; Matthew D Wilkerson; C Ryan Miller; Li Ding; Todd Golub; Jill P Mesirov; Gabriele Alexe; Michael Lawrence; Michael O'Kelly; Pablo Tamayo; Barbara A Weir; Stacey Gabriel; Wendy Winckler; Supriya Gupta; Lakshmi Jakkula; Heidi S Feiler; J Graeme Hodgson; C David James; Jann N Sarkaria; Cameron Brennan; Ari Kahn; Paul T Spellman; Richard K Wilson; Terence P Speed; Joe W Gray; Matthew Meyerson; Gad Getz; Charles M Perou; D Neil Hayes Journal: Cancer Cell Date: 2010-01-19 Impact factor: 31.743
Authors: Charles J Vaske; Stephen C Benz; J Zachary Sanborn; Dent Earl; Christopher Szeto; Jingchun Zhu; David Haussler; Joshua M Stuart Journal: Bioinformatics Date: 2010-06-15 Impact factor: 6.937
Authors: Vahe Michael Zohrabian; Brian Forzani; Zeling Chau; Raj Murali; Meena Jhanwar-Uniyal Journal: Anticancer Res Date: 2009-01 Impact factor: 2.480
Authors: Pau Creixell; Jüri Reimand; Syed Haider; Guanming Wu; Tatsuhiro Shibata; Miguel Vazquez; Ville Mustonen; Abel Gonzalez-Perez; John Pearson; Chris Sander; Benjamin J Raphael; Debora S Marks; B F Francis Ouellette; Alfonso Valencia; Gary D Bader; Paul C Boutros; Joshua M Stuart; Rune Linding; Nuria Lopez-Bigas; Lincoln D Stein Journal: Nat Methods Date: 2015-07 Impact factor: 28.547
Authors: Hung Nguyen; Duc Tran; Jonathan M Galazka; Sylvain V Costes; Afshin Beheshti; Juli Petereit; Sorin Draghici; Tin Nguyen Journal: Nucleic Acids Res Date: 2021-07-02 Impact factor: 16.971
Authors: Gabriel M Altschuler; Oliver Hofmann; Irina Kalatskaya; Rebecca Payne; Shannan J Ho Sui; Uma Saxena; Andrei V Krivtsov; Scott A Armstrong; Tianxi Cai; Lincoln Stein; Winston A Hide Journal: Genome Med Date: 2013-07-26 Impact factor: 11.117